Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, June 23, 2022

Cerebrospinal fluid volume improves prediction of malignant edema after endovascular treatment of stroke

This prediction doesn't do one damn bit of good unless you have EXACT PROTOCOLS  to prevent this edema from happening. 

Cerebrospinal fluid volume improves prediction of malignant edema after endovascular treatment of stroke

First Published May 12, 2022 Research Article Find in PubMed 

The ratio of intracranial cerebrospinal fluid (CSF) volume to intracranial volume (ICV) has been identified as a potential predictor of malignant edema formation in patients with acute ischemic stroke.

We aimed to evaluate the added value of the CSF/ICV ratio in a model to predict malignant edema formation in patients who underwent endovascular treatment.

We included patients from the MR CLEAN Registry, a prospective national multicenter registry of patients who were treated with endovascular treatment between 2014 and 2017 because of acute ischemic stroke caused by large vessel occlusion. The CSF/ICV ratio was automatically measured on baseline thin-slice noncontrast CT. The primary outcome was the occurrence of malignant edema based on clinical and imaging features. The basic model included the following predictors: age, National Institutes of Health Stroke Scale, Alberta Stroke Program Early CT score, occlusion of the internal carotid artery, collateral score, time between symptom onset and groin puncture, and unsuccessful reperfusion. The extended model included the basic model and the CSF/ICV ratio. The performance of the basic and the extended model was compared with the likelihood ratio test.

Malignant edema occurred in 40 (6%) of 683 patients. In the extended model, a lower CSF/ICV ratio was associated with the occurrence of malignant edema (odds ratio (OR) per percentage point, 1.2; 95% confidence interval (CI) 1.1–1.3, p < 0.001). Age lost predictive value for malignant edema in the extended model (OR 1.1; 95% CI 0.9–1.5, p = 0.372). The performance of the extended model was higher than that of the basic model (p < 0.001).

Adding the CSF/ICV ratio improves a multimodal prediction model for the occurrence of malignant edema after endovascular treatment.

The occurrence of malignant edema may require timely decompressive surgery to prevent poor clinical outcomes in patients with acute ischemic stroke.1,2 Accurate prediction of malignant edema formation may help in making prompt treatment decisions. Important factors that have been associated with malignant edema include young age, high National Institutes of Health Stroke Scale (NIHSS), extensive early ischemic changes on noncontrast CT (NCCT), large perfusion deficits on CT perfusion, proximal thrombus location on CT angiography (CTA), and poor collateral filling in the affected area on CTA.3 The incorporation of these factors in multivariable models has led to reasonable discrimination between groups of patients with and without malignant edema, but predictive values for individual patients remain moderate.3

In a previous study, we found the ratio of intracranial cerebrospinal fluid (CSF) volume to intracranial volume (ICV) to be of added value in models predicting malignant edema in patients with acute ischemic stroke.4 Until now, this has not been validated in another cohort.

Recently, a prediction model for malignant edema after acute supratentorial ischemic stroke for which endovascular treatment (EVT) was performed has been developed based on the Multicenter Randomized Controlled Trial of Endovascular Treatment for Acute Ischaemic Stroke in the Netherlands (MR CLEAN) Registry.5 In this study, we tested the additional predictive value of the CSF/ICV ratio.

More at link.

 

No comments:

Post a Comment